Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Apr 16, 2018Acquisition launches women's health focus on cancer and may lead to new diagnostic options for ovarian cancer
Boston Scientific acquisition launches women's health focus on cancer and may lead to new diagnostic options for ovarian cancer.
-
Apr 3, 2018Acquisition strengthens electrophysiology cardiac ablation portfolio with thermal monitor
Acquisition strengthens electrophysiology cardiac ablation portfolio with thermal monitor
-
Mar 28, 2018U.K. Court Affirms that Edwards Lifesciences Infringes Boston Scientific Patent
U.K. court affirms that Edwards Lifesciences infringes Boston Scientific patent
-
Mar 21, 2018Acquisition expands portfolio with minimally invasive treatment option for patients with benign prostatic hyperplasia
Acquisition expands portfolio with minimally invasive treatment option for patients with benign prostatic hyperplasia
-
Mar 20, 2018
Data demonstrated RHYTHMIA™ Mapping System, paired with the INTELLAMAP ORION™ Mapping Catheter, safe and effective treatment for a variety of arrhythmias
-
Mar 5, 2018Acquisition expands endoscopic portfolio to include radiofrequency devices
Acquisition expands endoscopic portfolio to include radiofrequency devices
-
Feb 26, 2018
Boston Scientific announced its completed public offering of senior notes.
-
Feb 22, 2018
Boston Scientific announced the pricing of a public offering of senior notes.
-
Feb 1, 2018
"Our team delivered excellent fourth quarter and full year results, said chairman and CEO Mike Mahoney.
-
Jan 24, 2018Millipede, Inc. is developing the IRIS Transcatheter Annuloplasty Ring System to treat severe mitral regurgitation
Millipede, Inc. is developing the IRIS Transcatheter Annuloplasty Ring System to treat severe mitral regurgitation
-
Jan 12, 2018Randomized controlled trial demonstrates effectiveness of long-term treatment with sub-perception spinal cord stimulation
Randomized controlled trial demonstrates effectiveness of long-term treatment with sub-perception spinal cord stimulation
-
Jan 11, 2018System offers non-opioid treatment option with multiple therapies for people with chronic pain
System offers non-opioid treatment option with multiple therapies for people with chronic pain
-
Jan 9, 2018
Based upon preliminary unaudited financial information, the company generated approximately $2.41 billion in sales during Q4 2017.
-
Dec 11, 2017Platform Offers Physicians Advanced Technology to Treat Symptoms of Parkinson's disease
DBS platform offers physicians advanced technology to treat symptoms of Parkinson's disease
-
Nov 28, 2017
Company announces delay for commercialization of the LOTUS Edge™ Aortic Valve System in Europe and the U.S.
-
Nov 27, 2017
Boston Scientific will participate in the healthcare conference on December 7, 2017. A live webcast and replay will be available.
-
Nov 8, 2017American Heart Association, American College of Cardiology and Heart Rhythm Society Issue Updated Guidelines Underscoring Benefits of the S-ICD System
American Heart Association, American College of Cardiology and Heart Rhythm Society issue updated guidelines underscoring benefits of the S-ICD system
-
Nov 2, 2017Late-breaking Clinical Trial Data Presented at TCT 2017 with Simultaneous Publication in the Journal of the American College of Cardiology
Late-breaking data presented at TCT 2017 with simultaneous publication in the Journal of the American College of Cardiology
-
Oct 26, 2017
“We continue to invest in a deep and innovative portfolio and expand into faster-growing markets," said CEO Mike Mahoney.
-
Oct 2, 2017Acquisition to Strengthen Company's Electrophysiology Portfolio and Expand into "Single-Shot" Balloon Pulmonary Vein Isolation Treatments for Patients with Atrial Fibrillation
Acquisition to strengthen company's electrophysiology portfolio
- Sep 25, 2017
HeartLogic is the first and only heart failure diagnostic in an implantable device shown to provide weeks of advance notice of an impending heart failure event.
-
Sep 19, 2017Data Presented at Heart Failure Society of America's 21st Annual Scientific Meeting Demonstrate Alert Improves Heart Failure Risk Prediction
Data presented demonstrate alert improves heart failure risk prediction
-
Sep 18, 2017Patients with Severe Asthma Show Sustained Clinical Improvement
Boston Scientific (NYSE: BSX) today announced results from a three year follow-up cohort in its Post-FDA Approval Clinical Trial Evaluating Bronchial Thermoplasty (BT) in Severe Persistent Asthma...
-
Jul 27, 2017
"Our strong financial performance in the first half of 2017 reflects our innovative portfolio,” said CEO Mike Mahoney.
-
Jun 27, 2017
Investor meeting will cover Boston Scientific’s business and long-term growth strategies, including by expanding category leadership and driving global growth.
-
Jun 6, 2017Industry's First MR-Conditional Directional DBS System with Stimulation Visualization
Industry's first MR-conditional directional DBS System with stimulation visualization
-
May 24, 2017Results from Evaluation of Real-World Patients Presented at American Thoracic Society International Conference
Results from evaluation of real-world patients presented at American Thoracic Society International Conference
-
May 16, 2017
The first head-to-head pivotal study comparing two different TAVI platforms demonstrated the LOTUS™ Valve System’s superior efficacy.
-
May 16, 2017Acquisition Expands Company's Structural Heart Portfolio; Increases Offerings for the Treatment of Patients with Valvular Heart Disease
BAcquisition expands company's structural heart portfolio; increases offerings for the treatment of patients with valvular heart disease
-
May 12, 2017Largest Prospective Study of the WATCHMAN Device Presented as Late-Breaking Trial at Heart Rhythm 2017
Largest prospective study of the WATCHMAN device presented as late-breaking trial at Heart Rhythm 2017
-
May 12, 2017Analyses Evaluated the Impact of Ethnicity, Gender and Income on Cardiovascular Outcomes
Analyses evaluated the impact of ethnicity, gender and income on cardiovascular outcomes
-
May 11, 2017Late-Breaker Data Presented at Heart Rhythm 2017
Late-breaker data presented at Heart Rhythm 2017
-
May 9, 2017New Devices Combine Longest-Lasting Battery Technology, Therapy Optimization and HeartLogic™ Heart Failure Diagnostics
New devices combine longest-lasting battery technology, therapy optimization and HeartLogic™ heart failure diagnostics
-
Apr 27, 2017
"We are pleased with our performance in the first quarter,” said CEO Mike Mahoney
-
Apr 18, 2017MADIT S-ICD Trial to Study EMBLEM™ MRI Subcutaneous Implantable Defibrillator (S-ICD) System; Trial Recruitment Part of Pilot Initiative to Increase Percentage of Females Enrolled in Clinical Studies
MADIT S-ICD trial to study EMBLEM™ MRI S-ICD System; part of pilot initiative to increase percentage of females enrolled in clinical studies
-
Mar 30, 2017Acquisition Will Expand Treatments for Patients with Valvular Heart Disease and Strengthen Company's Position in Structural Heart Globally
Acquisition will expand treatments for patients with valvular heart disease and strengthen company's position in structural heart globally
-
Mar 16, 2017Extended battery life of Boston Scientific devices attributed to reduction in replacement procedures and complications; has potential for significant cost savings
Extended battery life of Boston Scientific devices attributed to reduction in replacement procedures and complications; potential for significant cost savings
-
Mar 9, 2017Edwards Found to Infringe on Boston Scientific Patents in Germany and U.K.
Edwards found to infringe on Boston Scientific patents in Germany and U.K.
-
Feb 2, 2017
"Boston Scientific delivered excellent financial results in 2016,” said CEO Mike Mahoney
-
Dec 13, 2016
Acquisition will bring manufacturing assets and biologic tissue capabilities for use in Boston Scientific heart valve technologies.
- Dec 2, 2016$75M transaction enhances manufacturing expertise in structural heart
$75M transaction enhances manufacturing expertise in structural heart
Nov 22, 2016Acquisition Expands Endoscopy PortfolioAcquisition expands Boston Scientific endoscopy portfolio with a comprehensive array of gastrointestinal services and devices
- Nov 21, 2016
Boston Scientific today announced that its Cork, Ireland manufacturing facility has received the 2016 Shingo Prize for Excellence in Manufacturing from the Shingo Institute, part of the Jon M....
-
Nov 16, 2016Late-Breaking Trial Data Presented at AHA Scientific Sessions Demonstrate Success of Alert to Predict Worsening Heart Failure
Boston Scientific (NYSE: BSX) today announced results from the first clinical trial evaluating the performance of the HeartLogic™ Heart Failure Diagnostic Service to predict impending heart...
-
Nov 15, 2016Acquisition Advances Treatment Options for Women with Uterine Polyps
Boston Scientific (NYSE: BSX) has acquired the gynecology and urology portfolio of Distal Access, LLC, a Salt Lake City based company that designs minimally invasive medical devices. The portfolio...
-
Nov 8, 2016Kidney Stone Retrieval Device Enables Physicians to Release and Capture Kidney Stones of Multiple Sizes
MARLBOROUGH, Mass., (Nov. 8, 2016) – Boston Scientific Corporation (NYSE: BSX) today announced the U.S. and European launch of the Dakota™ Nitinol Stone Retrieval Device with OpenSure™...
-
Nov 3, 2016Technology to Improve Management of Gastrointestinal Diseases
Boston Scientific (NYSE: BSX) today announced the acquisition of the LumenR™ Tissue Retractor System from LumenR LLC, a privately held Newark, California based company. The LumenR Tissue...
-
Nov 2, 2016Late-Breaking Trial Data Presented at TCT Scientific Sessions and Simultaneously Published in the Journal of the American College of Cardiology
Boston Scientific (NYSE: BSX) announced initial U.S. commercial performance results of the WATCHMAN™ Left Atrial Appendage Closure (LAAC) Device today during a late-breaking clinical trial...
-
Nov 1, 2016The PLATINUM Diversity Study Provides Much Needed Data about Women and Minority Patients, Who are Under-represented in Cardiology Clinical Trials
As part of the commitment to support health equity for all patients, Boston Scientific Corporation (NYSE: BSX) sponsored the PLATINUM Diversity study to evaluate the clinical outcomes of the...
- Oct 26, 2016
Boston Scientific Corporation (NYSE: BSX) generated sales of $2.105 billion during the third quarter ended September 30, 2016, compared to the company's guidance range for the quarter of $2.035 to...
